Baseline neutrophil-to-lymphocyte ratio is associated with outcome in recurrent/metastatic head and neck squamous cell cancer patients treated with platinum and cetuximab in first line setting
2015 ◽
Vol 3
(4)
◽
pp. 839-842
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 9
(2)
◽
pp. 143-150
Keyword(s):
2019 ◽
Vol 15
(7)
◽
pp. 1336-1344
Keyword(s):
Keyword(s):
Keyword(s):